Disseminated varicella-zoster virus infections following messenger RNA–based COVID-19 vaccination
Jordan Taylor Said, BA,
Cesar A. Virgen, MD,
Christine G. Lian, MD,
Corey S. Cutler, MD, MPH,
Joseph F. Merola, MD, MMSc,
Nicole R. LeBoeuf, MD, MPH
Affiliations
Jordan Taylor Said, BA
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts
Cesar A. Virgen, MD
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
Christine G. Lian, MD
Harvard Medical School, Boston, Massachusetts; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts
Corey S. Cutler, MD, MPH
Harvard Medical School, Boston, Massachusetts; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts
Joseph F. Merola, MD, MMSc
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts
Nicole R. LeBoeuf, MD, MPH
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Correspondence to: Nicole R. LeBoeuf, MD, MPH, Department of Dermatology, Brigham and Women's Hospital, 375 Longwood Avenue, Boston, MA 02115.